FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

HM Golomb

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
HM Golomb
Fifty years of hairy cell leukemia treatments.
HM Golomb
Hairy cell leukemia: treatment successes in the past 25 years.
Everett E Vokes; Gary S Gordon; Charles Rudin; Ann M Mauer; Sylvia Watson; Stuart Krauss; R Arrieta; HM Golomb; Philip C Hoffman
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of HM Golomb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: HM Golomb
Fifty years of hairy cell leukemia treatments.
Leukemia & lymphoma 2011;52 Suppl 2():3-5.
2008: HM Golomb
Hairy cell leukemia: treatment successes in the past 25 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2607-9.
2001: Everett E Vokes; Gary S Gordon; Charles Rudin; Ann M Mauer; Sylvia Watson; Stuart Krauss; R Arrieta; HM Golomb; Philip C Hoffman
A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.
Investigational new drugs 2001;19(4):329-33.
2000: Everett E Vokes; Gary S Gordon; Ann M Mauer; Charles Rudin; Stuart A Krauss; Livia Szeto; HM Golomb; Philip C Hoffman
A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer.
Clinical lung cancer 2000;2(2):128-32.
2000: Q Gao; Marshall Horwitz; Diane Roulston; Fitsum G Hagos; N Zhao; E J Freireich; HM Golomb; Olufunmilayo I Olopade
Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
Genes, chromosomes & cancer 2000;28(2):164-72.
1998: Everett E Vokes; Rafat H Ansari; Gregory A Masters; Philip C Hoffman; A Klepsch; Mark J Ratain; David F Sciortino; T E Lad; Stuart Krauss; Paul A. Fishkin; HM Golomb
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1085-90.
1998: HM Golomb
Management of early-stage Hodgkin's disease: a continuing evolution.
Seminars in oncology 1998;25(4):476-82.
1998: Gregory A Masters; Ann M Mauer; Philip C Hoffman; D Wyka; Brian L Samuels; Stuart A Krauss; Sylvia Watson; HM Golomb; Everett E Vokes
A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(6):677-80.
1998: Gregory A Masters; Daniel J Haraf; Philip C Hoffman; LC Drinkard; Stuart A Krauss; Mark K Ferguson; J Olak; Brian L Samuels; HM Golomb; Everett E Vokes
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2157-63.
1998: Everett E Vokes; Gregory A Masters; Ann M Mauer; Philip C Hoffman; Sylvia Watson; HM Golomb
Ifosfamide-based three-drug combination regimens in non-small cell lung cancer.
Seminars in oncology 1998;25(1 Suppl 2):19-22.
1998: Gregory A Masters; Philip C Hoffman; LC Drinkard; Brian L Samuels; HM Golomb; Everett E Vokes
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
Seminars in oncology 1998;25(1 Suppl 2):8-14.
1998: Ann M Mauer; Gregory A Masters; Daniel J Haraf; Philip C Hoffman; S M Watson; HM Golomb; Everett E Vokes
Phase I study of docetaxel with concomitant thoracic radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):159-64.
1997: Everett E Vokes; Gregory A Masters; Ann M Mauer; Daniel J Haraf; Philip C Hoffman; HM Golomb
Clinical studies of docetaxel (Taxotere) and concomitant chest therapy.
Seminars in oncology 1997;24(4 Suppl 14):S14-26-S14-29.
1997: Everett E Vokes; Ann M Mauer; Philip C Hoffman; Gregory A Masters; Sylvia Watson; HM Golomb
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 12):S12-67-S12-69.
1997: Gregory A Masters; Philip C Hoffman; A Hsieh; LC Drinkard; R Mick; Brian L Samuels; A Guaspari; HM Golomb; Everett E Vokes
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):884-92.
1996: Everett E Vokes; Philip C Hoffman; Gregory A Masters; HM Golomb; LC Drinkard; Stuart A Krauss
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Seminars in oncology 1996;23(3 Suppl 7):15-8.
1996: Philip C Hoffman; Gregory A Masters; LC Drinkard; Stuart A Krauss; Brian L Samuels; HM Golomb; Everett E Vokes
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Seminars in oncology 1996;23(3 Suppl 6):11-5.
1996: Olufunmilayo I Olopade; Diane Roulston; T Baker; S Narvid; Michelle M Le Beau; E J Freireich; Richard A Larson; HM Golomb
Familial myeloid leukemia associated with loss of the long arm of chromosome 5.
Leukemia 1996;10(4):669-74.
1996: Everett E Vokes; Daniel J Haraf; Gregory A Masters; Philip C Hoffman; LC Drinkard; M Ferguson; J Olak; Sylvia Watson; HM Golomb
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Seminars in oncology 1996;23(2 Suppl 5):48-52.
1996: Gregory A Masters; Philip C Hoffman; LC Drinkard; Sylvia Watson; Brian L Samuels; HM Golomb; Everett E Vokes
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Seminars in oncology 1996;23(2 Suppl 5):11-8.
1996: Philip C Hoffman; Gregory A Masters; LC Drinkard; Stuart A Krauss; Brian L Samuels; HM Golomb; Everett E Vokes
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):314-6.
1995: Gregory A Masters; LC Drinkard; Philip C Hoffman; N Lane; Sylvia Watson; Brian L Samuels; Jacob Bitran; HM Golomb; Everett E Vokes
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
The cancer journal from Scientific American 1995;1(4):288-94.
1995: Philip C Hoffman; Stuart A Krauss; LC Drinkard; Gregory A Masters; Brian L Samuels; Jacob Bitran; HM Golomb; Sylvia Watson; Everett E Vokes
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Seminars in oncology 1995;22(4 Suppl 9):38-41.
1995: Gregory A Masters; HM Golomb
Management of pulmonary metastases.
Lancet 1995;346(8967):68.
1995: LC Drinkard; Philip C Hoffman; Brian L Samuels; Sylvia Watson; Jacob Bitran; HM Golomb; Everett E Vokes
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
Seminars in oncology 1995;22(2 Suppl 5):30-7; discussion 41-4.
1995: Everett E Vokes; Daniel J Haraf; LC Drinkard; Philip C Hoffman; Mark K Ferguson; Nicholas J Vogelzang; Sylvia Watson; N J Lane; HM Golomb
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Cancer chemotherapy and pharmacology 1995;35(4):304-12.
1994: HM Golomb; R Dodge; R Mick; D Budman; R Hutchison; S J Horning; Charles Alan Schiffer
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Leukemia 1994;8(12):2037-40.
1994: Everett E Vokes; LC Drinkard; Brian L Samuels; Philip C Hoffman; Sylvia Watson; Jacob Bitran; Daniel J Haraf; M F Ferguson; HM Golomb
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Seminars in oncology 1994;21(5 Suppl 10):79-83; discussion 83-4.
1994: P Kampmeier; R Spielberger; J Dickstein; R Mick; HM Golomb; James W Vardiman
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.
Blood 1994;83(10):2931-8.
1994: Everett E Vokes; Daniel J Haraf; Philip C Hoffman; Jacob Bitran; Mark K Ferguson; HM Golomb
Concomitant chemoradiotherapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S253-61.
1994: R T Spielberger; R Mick; Mark J Ratain; HM Golomb
Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986.
Leukemia & lymphoma 1994;14 Suppl 1():89-93.
1993: R T Spielberger; J I Dickstein; Michelle M Le Beau; Richard A Larson; K M Daly; James W Vardiman; HM Golomb
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
British journal of haematology 1993;83(3):519-20.
1992: Leonidas C Platanias; Lawrence M Pfeffer; K P Barton; James W Vardiman; HM Golomb; Oscar R Colamonici
Expression of the IFN alpha receptor in hairy cell leukaemia.
British journal of haematology 1992;82(3):541-6.
1992: HM Golomb; Mark J Ratain; R Mick; K Daly
Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986.
Leukemia 1992;6(11):1177-80.
1992: R T Spielberger; HM Golomb
Hairy cell leukemia 1992.
Leukemia 1992;6 Suppl 4():142-6.
1992: W J Gradishar; R Mick; Philip C Hoffman; Jacob Bitran; S Krishnasamy; Mark K Ferguson; HM Golomb
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer.
American journal of clinical oncology 1992;15(5):405-11.
1992: S H Wu; S Vedantham; M C Rosner; R M Lovis; HM Golomb; H Gamliel
Ultrastructural characteristics of the spleen in hairy cell leukemia.
Leukemia & lymphoma 1992;8(1-2):137-42.
1992: S Vedantham; H Gamliel; HM Golomb
Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Cancer research 1992;52(5):1056-66.
1992: HM Golomb; Mark J Ratain; R Mick; K Daly
The treatment of hairy cell leukemia: an update.
Leukemia 1992;6 Suppl 2():24-7.
1991: HM Golomb; E Ellis
Treatment options for hairy-cell leukemia.
Seminars in oncology 1991;18(5 Suppl 7):7-11.
1990: Leonidas C Platanias; Richard A Larson; James W Vardiman; H Reisel; HM Golomb; T W McKeithan
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression.
Leukemia 1990;4(12):863-5.
1990: J M Richards; R Mick; J M Latta; K Daly; Mark J Ratain; James W Vardiman; HM Golomb
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia.
Blood 1990;76(10):1941-5.
1990: WF Hartsell; R Farah; A Murthy; HM Golomb; R Weichselbaum
Is pelvic irradiation necessary in stage III1A Hodgkin's disease?
International journal of radiation oncology, biology, physics 1990;19(3):715-9.
1990: Mark K Ferguson; C Skosey; Philip C Hoffman; HM Golomb
Sex-associated differences in presentation and survival in patients with lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1402-7.
1990: Everett E Vokes; Srinivasan Vijayakumar; Philip C Hoffman; Mark K Ferguson; Jacob Bitran; S Krishnasamy; R Jacobs; HM Golomb
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer.
Cancer 1990;66(3):437-42.
1990: H Gamliel; B H Brownstein; D Gurfel; S H Wu; M C Rosner; HM Golomb
B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Cancer research 1990;50(13):4111-20.
1990: L L Doane; Mark J Ratain; HM Golomb
Hairy cell leukemia. Current management.
Hematology/oncology clinics of North America 1990;4(2):489-502.
1990: J A Moormeier; Stephanie F Williams; HM Golomb
The staging of non-Hodgkin's lymphomas.
Seminars in oncology 1990;17(1):43-50.
1990: Stephanie F Williams; Jacob Bitran; J M Richards; P J DeChristopher; E Barker; J Conant; HM Golomb; A R Orlina
Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach.
Bone marrow transplantation 1990;5(2):129-33.
1990: Olufunmilayo I Olopade; Richard A Larson; R Mick; S M Watson; Philip C Hoffman; J E Ultmann; HM Golomb
Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
Leukemia 1990;4(2):127-31.
1990: Teresa A Gilewski; HM Golomb
Design of combination biotherapy studies: future goals and challenges.
Seminars in oncology 1990;17(1 Suppl 1):3-10; discussion 38-41.
1989: R Farah; HM Golomb; Dennis E Hallahan; R K Desser; M L Griem; R Blough; J E Ultmann; Ralph R Weichselbaum
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.
International journal of radiation oncology, biology, physics 1989;17(4):761-6.
1989: Dennis E Hallahan; R Farah; Everett E Vokes; Jacob Bitran; J E Ultmann; HM Golomb; Ralph R Weichselbaum
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.
International journal of radiation oncology, biology, physics 1989;17(4):767-71.
1989: Heber MacMahon; W Scott; J W Ryan; S M Montner; A G Little; Philip C Hoffman; Mark K Ferguson; HM Golomb
Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer.
Cancer 1989;64(7):1404-8.
1989: J A Moormeier; Mark J Ratain; Carol A Westbrook; James W Vardiman; K M Daly; HM Golomb
Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
Journal of the National Cancer Institute 1989;81(15):1172-4.
1989: V H Gressler; R E Weinkauff; W A Franklin; HM Golomb
Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro?
Cancer 1989;64(2):374-8.
1989: Everett E Vokes; Jacob Bitran; Philip C Hoffman; Mark K Ferguson; Ralph R Weichselbaum; HM Golomb
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.
Chest 1989;96(1):110-3.
1989: J A Moormeier; Stephanie F Williams; HM Golomb
The staging of Hodgkin's disease.
Hematology/oncology clinics of North America 1989;3(2):237-51.
1989: T Lion; N Razvi; M A Hutchinson; HM Golomb; B H Brownstein
Rapid dot blot quantitation of viral DNA and amplified genes in less than 1,000 human cells.
DNA (Mary Ann Liebert, Inc.) 1989;8(5):361-7.
1989: Everett E Vokes; HM Golomb; B L Samuels; B H Brownstein
Heat shock proteins in normal and leukemic blood cells.
Journal of interferon research 1989;9(2):195-204.
1989: O L Olopade; John Anastasi; M Thangavelu; Michelle M Le Beau; HM Golomb
Cytogenetic abnormalities in a secondary lymphoma complicating cardiac transplantation.
Leukemia 1989;3(4):303-4.
1989: Stephanie F Williams; Jacob Bitran; Philip C Hoffman; E Robin; L Fullem; J Beschorner; J Golick; HM Golomb
High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer.
Cancer 1989;63(2):238-42.
1988: Mark J Ratain; James W Vardiman; C M Barker; HM Golomb
Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
Cancer 1988;62(11):2420-4.
1988: Mark J Ratain; HM Golomb; James W Vardiman; Carol A Westbrook; C Barker; A Hooberman; M A Bitter; K Daly
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(11):1714-21.
1988: T Lion; N Razvi; HM Golomb; R H Brownstein
B-lymphocytic hairy cells contain no HTLV-II DNA sequences.
Blood 1988;72(4):1428-30.
1988: HM Golomb; A Fefer; D W Golde; Howard Ozer; Carol S Portlock; R Silber; J Rappeport; Mark J Ratain; J Thompson; E Bonnem
Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.
Seminars in oncology 1988;15(5 Suppl 5):7-9.
1988: V H Gressler; R E Weinkauff; W A Franklin; HM Golomb
Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2.
Blood 1988;72(3):1048-53.
1988: James W Vardiman; Teresa A Gilewski; Mark J Ratain; M A Bitter; B A Bradlow; HM Golomb
Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique.
American journal of clinical pathology 1988;90(3):250-6.
1988: B C Lembersky; Mark J Ratain; HM Golomb
Skeletal complications in hairy cell leukemia: diagnosis and therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(8):1280-4.
1988: R Farah; J Ultmann; M Griem; HM Golomb; U Kalokhe; R Desser; R Blough; R Weichselbaum
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(6):1047-52.
1988: HM Golomb; Mark J Ratain; A Fefer; J Thompson; D W Golde; Howard Ozer; Carol S Portlock; R Silber; J Rappeport; E Bonnem
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
Journal of the National Cancer Institute 1988;80(5):369-73.
1988: H Gamliel; D Gurfel; S H Wu; HM Golomb
Interferon-induced surface alterations in hairy cells. A review.
Scanning microscopy 1988;2(1):485-92.
1988: B L Samuels; Richard A Larson; Michelle M Le Beau; K M Daly; M A Bitter; James W Vardiman; C M Barker; Janet D Rowley; HM Golomb
Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo.
Leukemia 1988;2(2):79-83.
1988: B C Lembersky; Mark J Ratain; Carol A Westbrook; HM Golomb
Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
American journal of hematology 1988;27(1):60-2.
1988: A Hiraoka; Nicholas J Vogelzang; M C Rosner; HM Golomb
Ultrastructure of four human germ cell tumor-derived cell lines: effect of 12-O-tetradecanoyl phorbol-13-acetate.
Cancer investigation 1988;6(4):393-402.
1987: K S Naunheim; J R Taylor; C Skosey; Philip C Hoffman; Mark K Ferguson; HM Golomb; A G Little
Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis.
The Annals of thoracic surgery 1987;44(5):462-6.
1987: R H Jacobs; A Awan; Jacob Bitran; Philip C Hoffman; A G Little; M K Ferguson; R Weichselbaum; HM Golomb
Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role.
Cancer 1987;59(12):2016-9.
1987: E E Vokes; M A Bitter; Mark J Ratain; Michael B Prystowsky; K Daly; HM Golomb
Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy.
Cancer 1987;59(12):1987-91.
1987: HM Golomb; A Fefer; D W Golde; Howard Ozer; Carol S Portlock; R Silber; J Rappeport; Mark J Ratain; J Thompson; E M Bonnem
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
Seminars in oncology 1987;14(2 Suppl 2):13-7.
1987: B L Samuels; HM Golomb; B H Brownstein
In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferon.
Blood 1987;69(6):1570-3.
1987: B L Samuels; HM Golomb; B H Brownstein
Different proteins are induced by alpha- and gamma-interferon in hairy cell leukemia.
Journal of biological response modifiers 1987;6(3):268-74.
1987: R G Bardawil; Mark J Ratain; HM Golomb; M A Bitter; C Groves; James W Vardiman
Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Leukemia 1987;1(4):340-3.
1987: B L Samuels; M C Rosner; C S Giometti; HM Golomb; B H Brownstein
Action of interferons in hairy cell leukemia.
Leukemia 1987;1(4):365-9.
1987: Mark J Ratain; HM Golomb; R G Bardawil; James W Vardiman; Carol A Westbrook; L S Kaminer; B C Lembersky; M A Bitter; K Daly
Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
Blood 1987;69(3):872-7.
1987: R H Jacobs; Jacob Bitran; M Deutsch; Philip C Hoffman; J Sinkule; S Purl; HM Golomb
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
Cancer treatment reports 1987;71(3):311-2.
1987: H Gamliel; A Hiraoka; HM Golomb
The effect of cultivation and interferon treatment on the surface morphology of hairy cell leukemia cells.
Cancer investigation 1987;5(5):389-99.
1987: B C Lembersky; HM Golomb
Hairy cell leukemia: clinical features and therapeutic advances.
Cancer metastasis reviews 1987;6(3):283-300.
1986: R H Jacobs; A Greenburg; Jacob Bitran; Philip C Hoffman; K S Albain; R Desser; L Potkul; HM Golomb
A 10-year experience with combined modality therapy for stage III small cell lung carcinoma.
Cancer 1986;58(10):2177-84.
1986: B L Samuels; HM Golomb; B H Brownstein
In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
Cancer research 1986;46(8):4151-5.
1986: K S Albain; Philip C Hoffman; A G Little; Jacob Bitran; HM Golomb; T R DeMeester; M L Griem; R R Blough; C Skosey
Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes.
American journal of clinical oncology 1986;9(3):255-61.
1986: M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; HM Golomb; J D Rowley
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):325-45.
1986: R G Bardawil; C Groves; Mark J Ratain; HM Golomb; James W Vardiman
Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia.
American journal of clinical pathology 1986;85(2):194-201.
1986: Jacob Bitran; HM Golomb; Philip C Hoffman; K Albain; R Evans; A G Little; S Purl; C Skosey
Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report.
Cancer 1986;57(1):44-53.
1986: H Gamliel; HM Golomb; E Avinoah; D Gurfel; Aaron Polliack
Topical modes in the preparation of human spleen specimens for routine scanning electron microscopy studies.
Scanning electron microscopy 1986;(Pt 3):1039-50.
1985: E R Gaynor; J E Ultmann; HM Golomb; D L Sweet
Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(12):1596-604.
1985: K V Shepard; HM Golomb; Jacob Bitran; Philip C Hoffman; S B Newman; T R DeMeester; C Skosey
CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients.
Cancer 1985;56(10):2385-90.
1985: Everett E Vokes; J E Ultmann; HM Golomb; E R Gaynor; D J Ferguson; M L Griem; D Oleske
Long-term survival of patients with localized diffuse histiocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(10):1309-17.
1985: K S Albain; L D True; HM Golomb; Philip C Hoffman; A G Little
Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations.
Cancer 1985;56(7):1618-23.
1985: A G Little; HM Golomb; Mark K Ferguson; C Skosey; D B Skinner
Malignant superior vena cava obstruction reconsidered: the role of diagnostic surgical intervention.
The Annals of thoracic surgery 1985;40(3):285-8.
1985: M A Cornbleet; Umberto Vitolo; J E Ultmann; HM Golomb; D Oleske; M L Griem; D J Ferguson; J B Miller
Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(6):758-68.
1985: H Gamliel; HM Golomb; D Gurfel; A Hiraoka; M C Rosner; Aaron Polliack
Hairy cell leukemia: reevaluation of cell surface features under the scanning electron microscope, using the "GTGO" air drying and critical point drying procedures.
Scanning electron microscopy 1985;(Pt 4):1665-78.
1984: P J Madej; Jacob Bitran; HM Golomb; P G Hoffman; T DeMeester; R K Desser; R Kaul; V Raghavan; S B Newman; C Skosey
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience.
Cancer 1984;54(1):5-12.
1984: K S Albain; Jacob Bitran; HM Golomb; Philip C Hoffman; T R DeMeester; C Skosey; S Noble; R R Blough
Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
Cancer treatment reports 1984;68(2):413-5.
1983: S B Newman; Jacob Bitran; Philip C Hoffman; V Raghaven; T R DeMeester; HM Golomb
Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung.
Cancer treatment reports 1983;67(9):831-2.
1983: S B Newman; T R DeMeester; HM Golomb; Philip C Hoffman; A G Little; V Raghavan
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
The Journal of thoracic and cardiovascular surgery 1983;86(2):180-5.
1983: HM Golomb; E H Kraut; D L Oviatt; E J Prendergast; Richard S Stein; D L Sweet
Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia.
American journal of hematology 1983;14(1):49-56.
1983: K S Albain; M M Le Beau; J W Vardiman; HM Golomb; J D Rowley
Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation.
Cancer genetics and cytogenetics 1983;8(2):107-15.
1983: Philip C Hoffman; S B Newman; HM Golomb; T R Demeester; R R Blough; C A Sovik
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
European journal of cancer & clinical oncology 1983;19(1):33-8.
1982: Jacob Bitran; D L Sweet; J Vardiman; HM Golomb; J E Ultmann
Histiocytic lymphoma: response to chemotherapy.
Annals of internal medicine 1982;97(4):617-8.
1982: E Robin; Jacob Bitran; HM Golomb; S Newman; Philip C Hoffman; R K Desser; T R DeMeester
Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases.
Cancer 1982;49(9):1916-9.
1982: S B Newman; J D Bitran; HM Golomb; Philip C Hoffman; T R DeMeester; V Raghavan
VP16-213 in combined modality treatment of small cell carcinoma of the lung.
European journal of cancer & clinical oncology 1982;18(4):343-6.
1981: D L Sweet; J Kinzie; M E Gaeke; HM Golomb; D L Ferguson; J E Ultmann
Survival of patients with localized diffuse histiocytic lymphoma.
Blood 1981;58(6):1218-23.
1981: J B Miller; D Variakojis; Jacob Bitran; D L Sweet; J J Kinzie; HM Golomb; J E Ultmann
Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction.
Cancer 1981;47(4):748-56.
1981: J R Kanofsky; HM Golomb; J E Vardiman; D L Sweet; J E Ultmann
Late relapses in Hodgkin disease.
American journal of hematology 1981;10(1):31-6.
1980: Philip C Hoffman; HM Golomb; Jacob Bitran; T R DeMeester; L Cohen; M L Griem; J A Cooksey; U Mintz; L I Gordon; R K Desser; A E Kinnealey; C A Sovik
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy.
Cancer 1980;46(12):2550-6.
1980: HM Golomb; D L Sweet; J E Ultmann; J B Miller; J J Kinzie; L I Gordon
Importance of substaging of stage III Hodgkin's disease.
Seminars in oncology 1980;7(2):136-43.
1980: D L Sweet; HM Golomb; J E Ultmann; J B Miller; Richard S Stein; E P Lester; U Mintz; Jacob Bitran; R A Streuli; K Daly; N O Roth
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.
Annals of internal medicine 1980;92(6):785-90.
1980: R A Streuli; J R Testa; J W Vardiman; U Mintz; HM Golomb; J D Rowley
Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies.
Blood 1980;55(4):636-44.